EFFECT OF PLAZEPOD VERSUS ELECTRICAL STIMULATION ON RISK OF FALLING IN HEMODIALYSIS PATIENTS

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age40-50
SponsorCairo University

About this trial

Renal nutrition Fluid control Safe physical activity Sleep hygiene, energy and managing fatigue Adherence and awareness

Eligibility criteria

Qualifiers

Male patients aged 40 to 50 years.

Diagnosed with end-stage renal disease and receiving maintenance hemodialysis for at least 6 months.

Medically stable and cleared by a nephrologist to participate in physical activity and/or electrical stimulation.

Able to ambulate independently or with minimal assistance.

Disqualifiers

Severe neurological or orthopedic disorders affecting mobility.

Unstable cardiovascular conditions.

Cognitive impairment or sensory deficits.

Contraindications to neuromuscular electrical stimulation.

Trial design

Treatments tested in this trial

  • Device + Behavioral
  • Neuromuscular Electrical Stimulation (NMES)

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators